% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

  • antisensehypsterss antisensehypsterss Feb 22, 2013 9:33 AM Flag


    Roche has reported
    that the U.S. Food and Drug Administration (FDA) has granted marketing approval
    to Kadcyla for the treatment of people with HER2-positive metastatic breast
    Looks linek no + surprise on the approved patient population.
    cancer who have received prior treatment with Herceptin(R)
    (trastuzumab) and a taxane chemotherapy.

2.92+0.02(+0.69%)Aug 26 4:00 PMEDT